[History of Bills, Volume 155 (2009)]
[From the U.S. Government Publishing Office, www.gpo.gov]


------------------------------------------------------
H.R. 1706--A bill to prohibit brand name drug companies from 
    compensating generic drug companies to delay the entry of a 
    generic drug into the market, and for other purposes; to the 
    Committee on Energy and Commerce, and in addition to the Committee 
    on the Judiciary, for a period to be subsequently determined by 
    the Speaker, in each case for consideration of such provisions as 
    fall within the jurisdiction of the committee concerned.


By Mr. RUSH (for himself, Mr. Waxman, Mr. Dingell, Mr. Doyle, Mr. 
Markey of Massachusetts, Mr. Stupak, Ms. Schakowsky, and Ms. DeGette), 
H4025 [25MR]

  Cosponsors added, H9730 [17SE]